Taking control of Ocular would also give Sanofi access to its drug delivery platform Elutyx, which could have applications ...

Scientists have transformed enigmatic cell structures, called vaults, into storage units for messenger-RNA molecules made in ...

Nitin Joshi, PhD, and Jingjing Gao, PhD, of the Department of Anesthesiology at Mass General Brigham, are the co-senior ...

Bayer's agrochemicals unit Monsanto has filed lawsuits in the US against the manufacturers of mRNA-based COVID-19 vaccines, ...

Covid vaccine makers Pfizer, BioNTech and Moderna are being sued for allegedly copying messenger RNA (mRNA) technology ...

A patient died after receiving Pfizer Inc.’s drug for hemophilia, marking another setback for the company in the treatment of blood disorders. The death occurred on Dec. 14 after the patient ...

Longtime Pfizer R&D chief Kathy Fernando, Ph.D., has left the Big Pharma behind to take on the role of chief business officer at San Diego biotech Replicate Bioscience. There, she’ll work to advance ...

With COVID sales falling and patent protections expiring, Pfizer is forecasting its 2026 revenue to be in the range of $59.5 billion to $62.5 billion. The midpoint of the projection ($61 billion) ...

Pfizer (PFE) reaffirmed its FY25 EPS guidance but trimmed its revenue outlook, while issuing FY26 EPS guidance that missed Wall Street expectations. The stock is trading sharply lower as investors ...

Dec 15 (Reuters) - Adaptive Biotechnologies (ADPT.O), opens new tab said on Monday it has signed two non-exclusive deals with Pfizer (PFE.N), opens new tab to support research in rheumatoid arthritis ...

Fresh off the acquisition of metabolic medicines developer Metsera, Pfizer is again turning to dealmaking to expand its obesity drug pipeline, this time picking up an experimental oral drug that could ...

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced it has entered into an exclusive global collaboration and license agreement with YaoPharma, a subsidiary of Shanghai Fosun ...